Senior Lecturer in Pathology
I am a Senior Lecturer in Pathology and year two lead in the School of Medicine. I am unit lead and contribute to teaching and learning in units related to mechanisms of disease and pregnancy and reproduction in phase one of the undergraduate MBChB Medicine degree.
Prior to joining the School of Medicine, I was Programme Leader and Senior Lecturer in the Bioscience Team. My research interests are focused on stem cell biology and childhood cancer research.
Teaching and supervision
I currently teach subject areas related to pathophysiology including mechanisms of human disease, cellular injury and adaptation, cancer biology and pathology.
I am a Senior Fellow of the Higher Education Academy with interests in models of patient simulation and the use of technology to enhance teaching and learning in higher education.
Research interests for potential research students
- The molecular and cellular analysis of childhood tumours, primarily neuroblastoma
- Cancer stem cell pathways and disease relapse (clonal evolution)
- LGR5 and the WNT signalling pathway in childhood cancer
- Stem cell models and differentiation
My research interests focus on understanding the genes and signalling networks underlying neuroblastoma development, relapse and chemoresistance, particularly the role of stem cell related genes. I am also interested in the use of stem cell models as a tool to study childhood cancer development and progression.
Furthermore, I am a co-investigator on a collaborative study with Newcastle University investigating mechanisms of neurotoxicity in primary neural cells lines and Induced Pluripotent Stem Cell (IPSC) derived neurons.
Elsana, Hassan, Olusanya, Temidayo O. B., Carr-Wilkinson, Jane, Darby, Steven, Faheem, Ahmed and Elkordy, Amal (2019) Evaluation of novel cationic gene based liposomes with cyclodextrin prepared by thin film hydration and microfluidic systems. Scientific Reports, 9 (15120).
Carr-Wilkinson, Jane, Prathalingam, Nilendran, Deepali, Pal, Moad, Mohammad, Lee, Natalie, Sundaresh, Aishwarya, Forgham, Helen, James, Peter, Herbert, Mary, Lako, Majlinda and Tweddle, Deborah A (2018) Differentiation of Human Embryonic Stem Cells to Sympathetic Neurons: A Potential Model for Understanding Neuroblastoma Pathogenesis. Stem Cells International. ISSN 0378-4274
Elsana, Hassan, Mysina, Svetlana, Elkordy, Emal Ali, Carr-Wilkinson, Jane and Elkordy, Amal (2018) Insights into the influences of carboxymethyl-β-cyclodextrin on DNA formulations characteristics and gene transfection efficiency. Current Drug Delivery, 15 (6). pp. 867-878. ISSN 1567 2018
Forster, Victoria, Carr-Wilkinson, Jane, Tweddle, Deborah A., Nakjang, Sirinita, Choufani, Sanaa, Weksberg, Rosanna and Van Delft, Frederick (2017) Investigating the mechanisms of methotrexate neurotoxicity in patients with childhood leukaemia and long-term survivors. Clinical Lymphoma Myeloma and Leukemia, 17 (2). S385 -S386. ISSN 2152-2650
Forgham, Helen, Johnson, Darren, Carter, Noel, Veuger, Stephany and Carr-Wilkinson, Jane (2015) Stem Cell Markers in Neuroblastoma—An Emerging Role for LGR5. Frontiers in Cell and Developmental Biology, 3 (77). ISSN 2296-634X
Carr-Wilkinson, Jane, Prathalingam, N, Pal, D, Moad, M, Lee, N, Sundaresh, A, Lako, M, Murdoch, A P, Herbert, M and Deborah, A (2013) Differentiation of human pluripotent stem cells to sympathetic neurons: A model for understanding neuroblastoma pathogenesis. Stem Cells and Translational Medicine. ISSN 2157-6564 (Submitted)
Moad, M, Pal, D, Hepburn, A C, Williamson, S C, Wilson, L, Lako, M, Armstrong, L, Hayward, S W, Franco, O E, Cates, J M, Fordham, S E, Przyborski, S, Carr-Wilkinson, Jane and Robson, C N (2013) A Novel Model of Urinary Tract Differentiation, Tissue Regeneration, and Disease: Reprogramming Human Prostate and Bladder Cells into Induced Pluripotent Stem Cells. European Urology. ISSN 0302-2838
Carr-Wilkinson, Jane, Wylie, Luke, Gray, Juliet and Anderson, John (2012) Neuroblastoma progress - future treatments for high risk neuroblastoma. Paediatric Blood and Cancer, 59 (3). pp. 594-596.
Carr-Wilkinson, Jane, Griffiths, R, Elston, R, Goranov, B, Redfern, C P F, Gamble, L D, Lunec, J and Tweddle, D A (2011) Outcome of the p53-mediated DNA damage response in neuroblastoma is determined by morphological subtype and MYCN expression. Cell Cycle, 10 (21). pp. 3778-3787. ISSN 1538-4101
Carr-Wilkinson, Jane, O'Toole, K, Wood, K M, Challen, C C, Baker, A G, Board, J R, Evans, L, Cole, M, Cheung, N V, Boos, J, Kohler, G, Leuschner, I, Pearson, A D J, Lunec, J and Tweddle, D A (2010) High frequency of p53/MDM2/p14ARF pathway abnormalities in relapsed neuroblastoma. Clinical Cancer Research, 16 (4). pp. 1108-1118. ISSN 1078-0432
Carr-Wilkinson, Jane, Bown, Nick P., Case, Marian C., Hall, Andrew G., Lunec, John and Tweddle, Deborah A. (2007) High-resolution analysis of allelic imbalance in neuroblastoma cell lines by single nucleotide polymorphism arrays. Cancer Genetics and cytogenetics, 172 (2). pp. 127-138.
Bell, Emma, Premkumar, Rakesh, Carr-Wilkinson, Jane, Lu, Xiahong, Lovat, Penny E., Kees, Ursula R., Lunec, John and Tweddle, Deborah A. (2006) The role of MYCN in the failure of MYCN amplified neuroblastoma cell lines to G1 arrest after DNA damage. Cell Cycle, 5 (22). pp. 2639-2647.
Carr-Wilkinson, Jane, Bell, Emma, Pearson, Andrew D. J., Kees, Ursula, Beris, Helen, Lunec, John and Tweddle, Deborah A. (2006) Increased frequency of aberrations in the p53/MDM2/p14ARF pathway in neuroblastoma cell lines established at relapse. The Journal of Cancer Research, 66 (4). pp. 2138-2145.
Carr-Wilkinson, Jane, Challen, Christine, Board, Julian, Wood, Katrina M., Pearson, Andrew D.J., Lunec, John and Tweddle, Deborah A. (2003) Selection for p53 mutant cells by chemotherapy in high-risk neuroblastoma. British Journal of Cancer, 88. s54. ISSN 0007-0920
Conference or Workshop Item
Elsana, Hassan, Carr-Wilkinson, Jane, Faheem, Ahmed and Elkordy, Amal (2018) Preparation, characterisation and cell transfection of cationic liposomes in gene therapy. In: APS@FIP Conference 2018, 7th September 2018, Glasgow.
Mysina, Svetlana, Ahmed, Shafiq, Michaelis, Martin, Cinatl Jr, Jindrich, Adejuwon, Damilola, Zaka, Masood and Carr-Wilkinson, Jane (2018) Investigating the role of cancer stem cell related genes in acquired drug resistance in neuroblastoma. In: Advances in Neuroblastoma Research 2018, May 9th -12th 2018, San Francisco.
Elsana, H, Carr-Wilkinson, Jane and Elkordy, Amal (2016) Carboxymethyl beta cyclodextrin to protect DNA formulations. In: 10th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 4-7 Apr 2016, Scottish Exhibition + Conference Centre, Glasgow, UK. (Unpublished)
Elsana, Hassan, Carr-Wilkinson, Jane and Elkordy, Amal (2016) Effects of cyclodextrin on DNA formulations: A preliminary study for gene therapeutics. In: Research Conference, 7 Jan 2016, University of Sunderland, UK.. (Unpublished)
Carr-Wilkinson, Jane (2015) Differentiation of human embryonic stem cells to sympathetic neurons: A potential model for understanding neuroblastoma pathogenesis. In: American Association for Cancer Research: Developmental Biology and Cancer, 30 Nov-3 Dec 2015, Boston, USA. (Submitted)
Carr-Wilkinson, Jane (2015) High LGR5 expression is associated with an aggressive phenotype in neuroblastoma cells. In: American Association for Cancer Research: Developmental Biology and Cancer, 30 Nov-3 Dec 2015, Boston, USA. (Submitted)
Carr-Wilkinson, Jane (2013) Using human embryonic stem cells to understand the pathogenesis of neuroblastoma. In: Neuroblastoma Symposium, 2013, Liverpool, UK. (Unpublished)
Carr-Wilkinson, Jane (2011) From human embryonic stem cells to sympathetic neurones: Understanding the pathogenesis of neuroblastoma. In: International Society for Stem Cell Research, 2011, Toronto, Canada. (Unpublished)
Carr-Wilkinson, Jane (2010) From human embryonic stem cells to sympathetic neurones: Understanding the pathogenesis of neuroblastoma. In: Neuroblastoma Society Research Symposium, 2010, Cambridge, UK. (Unpublished)
Carr-Wilkinson, Jane (2010) The role of the p53/MDM2/p14ARF axis in neuroblastoma pathogenesis. In: Newcastle University Medical Faculty Research Day 2010, 2010, Newcastle, UK. (Unpublished)
Carr-Wilkinson, Jane (2007) Increased frequency of p53/MDM2/p14ARF aberrations following cytotoxic therapy in neuroblastoma. In: National Cancer Research Meeting, 2007, Birmingham, UK. (Unpublished)
Carr-Wilkinson, Jane (2007) Increased frequency of p53/MDM2/p14ARF aberrations following cytotoxic therapy in neuroblastoma. In: International p53 workshop, 2007, Lyon, France. (Unpublished)
Carr-Wilkinson, Jane (2006) Comparison of Single-Nucleotide Polymorphism Arrays, Comparative Genomic Hybridisation and Conventional Karyotyping To Detect Allelic Imbalance in Neuroblastoma Cell Lines. In: Advances in Neuroblastoma Research, 2006, Los Angeles, USA.
Carr-Wilkinson, Jane (2005) Aberrations of the p53/p14ARF/MDM2 pathway in neuroblastoma cell lines derived from progressive and/or relapsed tumours. In: American Association for Cancer Research, 2005, California, USA. (Submitted)
Carr-Wilkinson, Jane (2004) Selection for p53 mutant cells by cytotoxic agents in neuroblastoma. In: Advances in Neuroblastoma Research, 2004, Genoa, Italy. (Unpublished)
Carr-Wilkinson, Jane (2003) Selection for p53 mutant cells by chemotherapy in high-risk neuroblastoma. In: British Association for Cancer Research Meeting, 2003, Bournemouth, UK. (Unpublished)
- Cancer stem cells and neuroblastoma
- Stemness genes and acquired drug resistance
- Stem cell models of childhood cancer
- Induced pluripotent stem cell models of neurotoxicity